PALO ALTO, Calif., June 6 /PRNewswire/ -- Frost & Sullivan is pleased to present Respironics with the 2006 Frost & Sullivan Award for Market Leadership in the sleep diagnostic device market based on the company’s continued market leadership, strategic advancement, technology innovation, and the ability to adapt.
Respironics, the market share leader in the sleep therapeutics market, boasts six consecutive quarters of two to three times the market growth in the sleep diagnostic segment. The core strength of Respironics lies in its wide coverage of all areas of respiratory and sleep diagnosis/therapy products and its continued technology innovation. Their growth in sleep diagnostics is due, in part, to an expanding portfolio of solutions that include the new Alice 5 Sleep System, Alice Sleepware software, interactive training tools and expanded accessory options.
Alice 3 was the first sleep diagnostic platform introduced by Respironics in 1991. It is by far one of the most popular and reliable sleep diagnostic systems ever introduced, and despite all the new quality systems available in the market, including the Alice 5, Respironics continues to manufacture this legendary platform due to continuing demand.
The sleep service provider network is a very demanding and unforgiving end-user. However, Respironics continues to expand its market share, offering reliable and effective methods of diagnosis that could cover all areas of sleep disorders.
“The Alice 5 has strengthened the sleep labs’ diagnostic capabilities while maintaining the high level of reliability that Respironics’ customers are accustomed to,” says Frost & Sullivan Research Analyst Mike Arani. “The company has expanded the signal collection capabilities of Alice 5 even further to meet cardiologists’ and neurologists’ demand for sleep neurophysiologic data.”
An impressive and highly effective strategy at Respironics’ has been the focus on the customer relationship from sales to business development services. The company has developed a skillful and knowledgeable sales and support workforce to meet the demands of the sleep service provider network, the major end-user of the sleep diagnostic device market. This workforce includes sleep sales consultants, diagnostic sales representatives, territory- specific account managers, installation and training groups, internal support groups, and IT specialists.
“These specialized groups work together to ensure a smooth process, from product demonstration to sales, installation, training, and network support,” notes Arani. “The sleep consultants also provide business development and growth strategies for individual sleep facilities.”
Overall, Respironics’ success has been due to a thorough understanding of the sleep and respiratory market as well as the development of a broad portfolio covering a complete set of sleep and respiratory solutions. In recognition of its market dominance, Frost & Sullivan is proud to present Respironics with the 2006 Frost & Sullivan Award for Market Leadership in the sleep diagnostic device market.
Each year Frost & Sullivan presents this Award to a company that has exhibited market share leadership through the implementation of market strategy. The recipient has displayed excellence in all areas of the market leadership process, including the identification of market challenges, drivers and restraints, as well as strategy development and methods of addressing these market dynamics. Furthermore, the Award recipient has continually demonstrated solutions for monitoring market changes and for implementing superior market strategies.
Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.
About Respironics
Respironics is a leading developer, manufacturer, and distributor of innovative products and programs that serve the global sleep and respiratory markets. Focusing on emerging market needs, the Company is committed to providing valued solutions to help improve outcomes for patients, clinicians and health care providers. Respironics markets its products in 131 countries and employs more than 4,600 associates worldwide. Further information can be found on the Company’s Web site: http://www.respironics.com .
About Frost & Sullivan
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company’s industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit http://www.awards.frost.com or http://www.patientmonitoring.frost.com
Contact: Stacie Jones 210.247.2450 Stacie.jones@frost.com
Frost & Sullivan
CONTACT: Stacie Jones of Frost & Sullivan, +1-210-247-2450, orStacie.jones@frost.com
